Drugs / Lipoaspirate Micronized
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT05517434 | Jan 2025 → Jun 2026 overdue | osteoarthritis, knee | University Health Network, Toronto | Recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lipoaspirate Micronized | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05517434 ↗ |
| Known as | LAM | “Lipoaspirate Micronized + Leukocyte-Poor Platelet-Rich Plasma (LAM + LP-PRP): Minimally manipulated autologous cellular preparations” NCT05517434 ↗ |
| Modality | Cell therapy | “minimally manipulated autologous cellular preparations” NCT05517434 ↗ |
| Route | Other | “9 mL (or less) of LAM is injected first” NCT05517434 ↗ |